Endothelin-3: selectivity as an anti-aggregatory peptide in vivo
- 1 July 1989
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 166 (2), 335-338
- https://doi.org/10.1016/0014-2999(89)90079-4
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes.Proceedings of the National Academy of Sciences, 1989
- Rat endothelin is a vasodilator in the isolated perfused mesentery of the ratEuropean Journal of Pharmacology, 1989
- Studies with Endothelin-3 and Endothelin-1 on Rat Blood Pressure and Isolated TissuesJournal of Cardiovascular Pharmacology, 1989
- Endothelin-1 Releases Eicosanoids from Rabbit Isolated Perfused Kidney and SpleenJournal of Cardiovascular Pharmacology, 1989
- Endothelin-1 Releases Prostacyclin and Inhibits ex vivo Platelet Aggregation in the Anesthetized RabbitJournal of Cardiovascular Pharmacology, 1989
- Endothelin inhibits ex vivo platelet aggregation in the rabbitEuropean Journal of Pharmacology, 1988
- Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide.Proceedings of the National Academy of Sciences, 1988
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988